Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Clinical trial NCT01358357 · COMPLETED

Trial details

NCT number: NCT01358357
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2011-06-01
Primary completion: 2015-04-01
Enrollment: 965

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.